
![]() |
¡¡¡¡Cell Research (2003); 13(4):251-264 |
Embryonic stem cells generated by nuclear transfer of human
somatic nuclei into rabbit oocytes
Download the PDF
file of this paper
Ying CHEN1,2 ,Zhi Xu HE3, Ailian LIU1,2, Kai WANG1,2, Wen Wei MAO1,2,Jian Xin CHU1,2, Yong LU1,2, Zheng Fu FANG1,2, Ying Tang SHI1,2, Qing Zhang YANG1,2, Da Yuan CHEN4, Min Kang WANG4, Jin Song LI4, Shao Liang HUANG3, Xiang Yin KONG5, Yao Zhou SHI5, Zhi Qiang WANG5, Jia Hui XIA6, Zhi Gao LONG6, Zhi Gang XUE6, Wen Xiang DING7, Hui Zhen SHENG1,2*
1Center for
Developmental Biology, Shanghai Second Medical University, Shanghai 200092,
China
2Laboratory of Stem Cell Biology, Institute of Biochemistry
and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences,1665 Kong Jiang Road, Shanghai 200092, China
3Center
for Stem Cell Research, the Second Affiliated Hospital, Sun Yat-Sen
University,Guangzhou 510120,China
4State Key Laboratory of
Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, 19
Zhong-guan Cun Road, Haidian District, Beijing 100080,
China
5Health Science Center, Shanghai Institutes of Biological
Sciences, Chinese Academy of Sciences and Shanghai Second Medical University,
Shanghai 200025, China
6National Laboratory of Medical Genetics,
Central South University, 88 Xiangya Road, Changsha 410078,
China
7Xinhua Hospital, Shanghai Second Medical University, 1665
Kong Jiang Road, Shanghai 200092, China
*Corresponding author:
Dr. Hui Zhen SHENG, Center for Developmental Biology, 1665 Kong Jiang Road,
Xinhua Hospital, Shanghai Second Medical University, Shanghai, 200092 China.
Telephone and fax number: 86-21-55570017. E-mail: hzsheng@sh163a.sta.net.cn
Dr. Hui Zhen SHENG is also an adjunct faculty member in the Department of Pharmacology/Cecil
H. & Ida Green Center for Reproductive Biology Sciences, The University
of Texas, Southwestern Medical Center, Dallas, TX, US
ABBREVIATIONS:
NT,
nuclear transfer; ntES cells, embryonic stem cells derived from somatic cells by
NT; EBs, embryoid bodies; SCNT, somatic cell nuclear transfer; FBS, fetal bovine
serum.
Received Aug-4-2003 Revised Aug-11-2003 Accepted Aug-13-2003
ABSTRACT
To solve the problem of immune
incompatibility, nuclear transplantation has been envisaged as a means to
produce cells or tissues for human autologous transplantation. Here we have
derived embryonic stem cells by the transfer of human somatic nuclei into rabbit
oocytes. The number of blastocysts that developed from the fused nuclear
transfer was comparable among nuclear donors at ages of 5, 42, 52 and 60 years,
and nuclear transfer (NT) embryonic stem cells (ntES cells) were subsequently
derived from each of the four age groups. These results suggest that human
somatic nuclei can form ntES cells independent of the age of the donor. The
derived ntES cells are human based on karyotype, isogenicity, in situ
hybridization, PCR and immunocytochemistry with probes that distinguish
between the various species. The ntES cells maintain the capability of sustained
growth in an undifferentiated state, and form embryoid bodies, which, on further
induction, give rise to cell types such as neuron and muscle, as well as mixed
cell populations that express markers representative of all three germ layers.
Thus, ntES cells derived from human somatic cells by NT to rabbit eggs retain
phenotypes similar to those of conventional human ES cells, including the
ability to undergo multilineage cellular differentiation.
Key words:
nuclear transfer (NT), somatic cell nuclear transfer (SCNT), embryonic stem
cells (ES cell), therapeutic cloning, rabbit oocyte.
INTRODUCTION
We hypothesized that somatic
nuclei from a human patient could be reprogrammed by nuclear transfer (NT) into
an oocyte to generate nuclear transfer embryonic stem cells (ntES cells). Cells
or tissue derived by this pathway would have nuclear DNA identical to the
patient's and, therefore, would likely not be subject to immune rejection[1-3].
In cows and mice, NT technology and ES cell derivation have been used
successfully in combination to establish ES or ES-like cell lines from
reprogrammed somatic cell nuclei[4-7], and mouse ntES cells have been shown to
be fully pluripotent[7].
The approach of nuclear
transplantation promises a solution to the central problem of immune
incompatibility. However, the feasibility of this approach has yet to be tested,
and many issues remain unanswered in this field. We do not know whether the use
of somatic cell NT (SCNT) to produce embryonic stem cells, successful in many
other species, would find similar success in humans. This is critical because
SCNT in monkeys results in a high degree of genetic instability[8]. If
successful, whether the age of the donor of the nucleus would become an
important factor in terms of the efficacy of SCNT is also not known. This is a
serious consideration because a large proportion of patients who might benefit
from this technology would be of advanced age. Questions also remain as to
whether ES cells can be derived from the oocytes carrying human somatic cell
nuclei (the ¡°nt-units"), and whether ES cells derived from these nt-units are
capable of somatic differentiation into various cell
types.
Mechanisms regulating early embryonic development
may be conserved among mammalian species, in that bovine oocyte cytoplasm
supports early development of nt-units from many mammalian species including
cow, sheep, pig, monkey, rat[9], and human[2]. In addition, rabbit oocyte
cytoplasm has been shown to support the full-term development of nt-units reconstructed with rabbit morula[10] and somatic cells[11] as nuclear
donors. In an interspecies NT experiment, rabbit oocytes have been used to
reprogram Panda somatic nuclei and have supported development of nt-units to the
blastocyst stage[12]. In this study, we tested rabbit oocyte cytoplasm as a
means to reprogram human somatic cell nuclei, and demonstrate that the derived
cells possess the properties and phenotypes of conventional human ES cells, that
they retain a normal karyotype, and that they are capable of multilineage
cellular differentiation.
MATERIALS AND
METHODS
Preparation of recipient oocytes and fibroblasts for
NT
Oocytes were collected from oviducts of
superovulated New Zealand rabbits 14.5 h after injection with human chorionic
gonadotropin. The procedure was proved by the Bioethical Committee of Shanghai
Second Medical University. Cumulus cell/oocyte complexes were dissected out from
the oviduct and incubated in M2 medium (M5910, Sigma) containing hyaluronidase
(300 units/ml, Sigma) for 3-5 min at room temperature (23¡æ to 25¡æ ).
The complexes were then pipetted
several times to dissociate cumulus cells
from oocytes. Fibroblasts were cultured in 5% CO2/95% air (37¡æ ) in
DMEM (GIBCO/BRL), supplemented with 15% fetal bovine serum (FBS, Hyclone) and 50
units/ml penicillin-streptomycin (GIBCO/BRL).
Micromanipulation
Oocytes were incubated in M2
medium with 7.5 ¦Ìg/ml cytochalasin B and Hoechest 33342 (5 ¦Ìg/ml) in 5%
CO2/95% air (38¡æ) for 10 min. Enucleation was performed by aspirating
the first polar body and M-phase chromosomes with a 15 to 20 ¦Ìm outer diameter
pipette. The successful enucleation was confirmed by visualizing the karyoplast
under UV light[10]. A single donor cell was inserted into the perivitelline
space of each enucleated oocyte using the same pipette.
Electrofusion and culture
of nt-units
The fibroblast/oocyte complex was equilibrated at room
temperature in a glucose solution (0.3 M) glucose/0.1 mM MgCl2/0.05
mM CaCl2; Sigma) for 5 to 10 min and placed between two electrodes (0.5 mm
apart) in a cell fusion chamber of an electrofusion apparatus (Model ECM 830,
BTX, San Diego) overlaid with the glucose solution. Electrical pulses (2.4
kv/cm, 60¦Ìsec, 3 direct current pulses, with 1.0 sec interval) were applied to
fuse the fibroblast and oocyte membranes. After electrofusion, nt-units were
cultured in 50 ¦Ìl droplets of RD medium supplemented with 15% FBS under mineral
oil (Sigma) at 38¡æ, 5% CO2/95%
air.
ntES cell
culture
Inner cell masses of blastocysts were manually
dissected out and cultured at 37¡æ, 5% CO2/95% air on mitomycin C
(Sigma) treated or irradiated (55 Gy) feeder cells prepared from 13.5 day mouse
embryos[13]. Culture medium consisted of 80% DMEM (high glucose formulation, no
pyruvate), supplemented with 20% FBS/1 mM glutamine/0.1 mM 2-mercaptoethanol/1%
non-essential amino acid stock/50 units/ml penicillin-streptomycin. In early
stage experiments, leukemia inhibitory factor (10 ng/ml) was added to the
medium. This component was omitted after it was shown that growth of ntES cells
was independent of added leukemia inhibitory factor. In some cases, ntES cells
were cultured in 80% Knockout medium (GIBCO/BRL), supplemented with 20\%
Knockout Serum Replacement (GIBCO/BRL)/4 ng/ml basic fibroblast growth factor/50
units/ml penicillin-streptomycin[13-15]. ntES cells could also be maintained in
the medium used for culture of embryonic germ cells[16]. Several days after
plating the inner cell mass, a colony of cells with a distinct border develops,
composed of mainly undifferentiated stem cells. Subsequent passages of ntES
cells were performed using either mechanic dispersion or enzymatic digestion
(collagenase IV, 1 mg/ml in DMEM medium, 37¡æ, 5% CO295% air for 3 to 5 min), or
the combination of both[13-15]. ntES cells at various passages were
cryopreserved and recovered successfully.
Immunohistochemistry
Monoclonal mouse
anti-human neurofilament protein and monoclonal mouse anti-nestin were obtained
from Chemicon. Monoclonal antibodies against human¦Á-smooth muscle actin, MyoD1,
and polyclonal rabbit antibodies against human myoglobin, human von Willebrand
Factor, human ¦Á-1-antitrypsin and neuron specific enolase were from DAKO.
Polyclonal rabbit anti-Tie-2 and¦Á-fetoprotein were purchased from Santa Cruz
Biotechnology. Monoclonal anti-VEGF receptor-2 and ¦Â-tubulin were obtained from
Sigma. The SSEA-1, SSEA-3, SSEA-4, TRA-1-10, and TRA-1-85 monoclonal antibodies
were obtained from Developmental Hybridoma Bank (Iowa city, IA). All antibodies
used have been shown to react specifically to the appropriate antigens. The
specificity of each of the antibodies is further verified by positive and
negative controls included in each experiment. Biotin and FITC labeled secondary
antibodies came from Jackson Immunoresearch. Indirect immunohistochemistry was
performed with the Vectastain ABC system (Vector Laboratories) using 3,
3'-diaminoanobenzidine as a substrate. Positive staining was brown on a blue
background counterstained with hematoxylin. Alkaline phosphatase activity was
detected by
using nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate
(Roche) as a substrate. To detect fat droplets, cells were fixed in 4%
formaldehyde for 1 h, washed with 70% ethanol, and incubated in 2% Oil Red O for
5 min at room temperature, followed by additional washes in 70% ethanol and
water.
DNA
genotyping
Total genomic DNA was extracted by using
standard procedures[17] from 1x105 fibroblasts or differentiated ntES cells. DNA
from both samples was amplified with 14 microsatellite markers (D3s1358, vWA,
FGA, Amelogenin, D8s1179, D21s11, D18s51, D5s818, D13s317, D7s820, D16s539,
TH01, TPOX, CSF1PO, also see Fig 9 legend) and analyzed on an ABI3100 Genetic
Analyzer.
In situ hybridization
with digoxigenin-labeled Alu DNA probes
Partially
differentiated ntES colonies were manually picked from the culture, fixed in 4%
paraformaldehyde, and embedded in paraffin. Freshly dissected rabbit and mouse
ovaries were embedded using the same protocol. DNA-DNA in situ hybridization was
as described previously[18-19]. Briefly, tissues were sectioned 5 ¦Ìm, digested
in proteinase K (10 ¦Ìg/ml) at 37¡æ for 15 min, and
post-fixed in 0.4% paraformaldehyde. The probe cocktail was composed of 10 of 50
x Denhardt's solution, 50 ul dextran sulfate, 100 ¦Ìl 20 x SSC, 500 ng
digoxigenin-labeled Alu probe in 50 ¦Ìl Tris/EDTA buffer, and distilled water to
make a total volume of 250 ¦Ìl. Formamide (250 ¦Ìl) was then added to complete the
preparation. Hybridization was carried out in a humidified chamber at 85
¡æ¡¡for 10 min, cooled on ice for 5 min, incubated in 42¡æ for 3 h, washed in
succession in 2xSSC, 0.1xSSC, buffer 1 (0.1 M maleic acid, 0.15 M NaCl, pH 7.5)
and 0.5 % blocking reagent (Roche) in buffer 1. After incubation with
anti-digoxigenin-alkaline phosphatase conjugate (Roche), color was developed by
incubation with nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate
(Roche).
In situ hybridization
with fluorescence-labeled probes specific for rabbit mitochondrial DNA
To generate rabbit mitochondrial DNA probes, the
rabbit mitochondrial genome (NC-00913)was compared to the human mitochondrial
genome (NC-001807). Three overlapping fragments covering 11713 bp (4883-16596)
of the rabbit mitochondrial genome were generated by PCR using the following
primer sets: 5' cgcatacccctcatcact 3', 5' gggaatatgataattaaggc 3'
(4883-8036); 5' ctatctattgtttagactcgc 3', 5' cggcgttgtatagttatggt-3'
(7708-13676); 5'-ttgcaggattcttaatttcc-3', 5' taaatactgtgcggtgat-3'
(13159-16596). The fragments were purified by gel electrophoresis, labeled with
digoxigenin-11-dUTP (Boehringer Mannheim), ethanol precipitated and
dissolved in a buffer composed of 50% deionized formamide, 2xSSC, 50 mM sodium
phosphate buffer, pH 7.0, 10% dextran sulfate.
nt-units at the blastocyst stage, rabbit parthenogenotes, or pellets of human
fibroblasts were embedded in paraffin, sectioned to 4 ¦Ìm, and place on
aminopropyltriethoxysilane (APES)-treated slides. Alternatively, cells were
cultured on glass slides, fixed in 4% formaldehyde.
In situ hybridization was performed as described[20]. Cells fixed on slides were
treated with 0.1% pepsin (Sigma), pH 2.0 at
37 ¡æ for 2 min. For tissue sections, slides were incubated in 0.2 N HCl at room temperature for 10 min and then with 0.1% pepsin, pH 2.0 at 37¡æ for 7 min. Samples were post-fixed and dehydrated. After application of the hybridization mix (6 ng/¦Ìl of probes in 2xSSC, 50% formamide), slides were incubated in 82¡æ for 3 min and then in 37¡æ overnight. After washing, digoxigenin labeled probes were detected with a mouse anti-digoxigenin antibody (Roche) and a Cy3 labeled donkey anti-mouse IgG secondary antibody (Jackson Immunoresearch). In some cases, samples were counterstained with DAPI to highlight nuclei.
PCR
One to three ntES colonies were manually removed from the dish and dissociated
with 0.25% trypsin/EDTA (GIBCO) for 30 min, with hyaluronidase (300 U/ml) at 37¡æ
for 30 min, followed by proteinase K (400 ¦Ìg/m in 0.005% SDS) at 50¡æ for 4 h.
DNA samples were prepared from rabbit tissue, 1 ml peripheral human blood or
1x103 mouse fibroblast cells using a standard protocol[17]. Primer sets used
were as follows: Human chromosome 7 alphoid repeats[21]:
5'
CAAGAAGGCTTCAAAGCACC 3', and 5' TTCATTGGAATCGCGAATAC 3'; Human keratin 9 gene
(Gi: 27484014):
5' GTTTTAGTGCCAGTAGTTTA 3, and 5' GTCCTTGAGATCATCAATAG3';
Mouse mG3PDH gene (Gi:10048294):
5' ATTCCTTGCCAAGAGGTGAC 3', and 5'
CAGCAAGGCAAGGTAGTGTG 3'; Rabbit whey acidic protein gene (WAP, Gi: 23957097): 5'
GGTTCCTTTGCAGGCACTTT 3', and 5' CGGCTCCCATCCTTCTCACT 3'. PCR reactions were
carried out using following parameters: 94¡æ for 4 min, 40 cycles at 94¡æ for 40
sec, 57¡æ for 30 sec, and 72¡æ for 30 sec; final extension was at 72¡æ for 10
min.
RESULTS
Reprogramming human smatic nuclei with rabbit
ooplasm
Foreskin tissue
from two 5-year-old males, one 42-year-old male, one 52-year-old male, and
facial skin tissue from a 60-year-old female were obtained from discarded tissue
after surgery. Fibroblasts were isolated and maintained in DMEM supplemented
with 15% FBS along with antibiotics and allowed to reach confluence. Cells from
passage 7 through 20 were used as nuclear donors. Oocytes from New Zealand
rabbits were enucleated as described[10]. After fusion, nt-units were allowed to
develop to the blastocyst stage at 38¡æ, 5% CO2 in RD medium
supplemented with 15% FBS. Fig 1A and Fig 1B exhibit an nt-unit developing through to the morula stage. Subsequently,
outer cells of the morula underwent flattening and the blastocoele became
visible (Fig 1C). As culture progressed, the blastocoele cavity
expanded and the inner cell mass became obvious at one side of the cavity. In
5-7 days, a proportion of the blastocysts hatched in culture. Fig 1D shows
a blastocyst carrying its inner cell
mass as it breaks through the zona pellucida. The identity of nt-units at
the blastocyst stage was analyzed by in situ hybridization with probes
specific for Alu repeats or rabbit mitochondrial DNA. Sections of nt-units at
the blastocyst stage hybridized to both probes, indicating that nt-units contain
the primate genome in combination with rabbit mitochondrial DNA (Fig
2).
These results verify that nt-units
at the blastocyst stage originate from human somatic cells reprogrammed by
rabbit oocytes, since embryos resulted from either natural mating or
parthenogenesis should contain the genomic and mitochondrial DNA of the same
species. Thus, rabbit oocytes are capable of at least partially reprogramming
human somatic cell nuclei based on development through preimplantation
stages.
To examine whether the age of somatic cell donors would
influence the effectiveness of SCNT, we conducted NT experiments with
fibroblasts from donors at four different ages (5, 42, 52 and 60 years) by using
identical electrofusion parameters and culture conditions. Numbers of nt-units
that proceeded through sequential developmental stages, including first
cleavage, morula, and blastocyst, were recorded and analyzed for each age group.
Statistic analysis (¦Ö2 test) showed that the number of nt-units at
early developmental stages varied significantly among different age groups [e.g.
a significant low percentage (52/240, 21.7%,P<0.01) of nt-units in the age 5
group and a significant high percentage (71/133, 53.4%,P<0.01) of nt-units in
the age 60 group went through initial division to enter 2- to 4-cell stage]. In
addition, a significantly high percentage of 2- to 4-cell stage nt-units
developed to blastocysts (28/52, 53.8%, P<0.01) in the age 5 group. These
results suggest that the rate of nt-units going through early developmental
stages may be influenced by the age of the nuclear donor. Overall, however,
there was no significant difference in the percentage of blastocysts that
developed from fused nt-units in the four age groups [11.7%, 10.4%, 12.7%, and
13.5% for ages 5, 42, 52, and 60 years, respectively (P>0.05); see Tab 1].
These data demonstrated that the potential of the human somatic cell nucleus to
be reprogrammed may not be diminished by aging, as judged by the ability of
nt-units to form blastocysts. It is consistent with results derived from both
mouse and bovine cloning experiments where somatic nuclei from adults were
successfully reprogrammed[22, 23].
| Age | No. of fused | No. of stage 2-4 cell | No. of blastocysts |
| (year) | nt-units* | (% of fused nt-units)** | (% of fused nt-units) |
| 5 | 240 | 52 (21.7) | 28 (11.7) |
| 42 | 221 | 87 (39.4) | 23 (10.4) |
| 52 | 300 | 111 (37.0) | 38 (12.7) |
| 60 | 133 | 71 (53.4) | 18 (13.5) |
* As assessed 0.5 h after fusion by examination
on an inverted microscope.
** Age 5 percentage is significantly different
from age 42, 52 and 60; and age 60 percentage is significantly different from
age 5, 42 and 52 (P<0.01).
Karyotype of nt-units
Fig 1E-G show a spindle structure of a human somatic
cell nucleus going through M phase during the first division in an oocyte, as
revealed by staining with propidium iodide and a ¦Â-tubulin specific
antibody[24]. The spindle of the nt-unit appeared normal. Under the light
microscope, we noted a high proportion of cytoplasmic division and incomplete
cell separation of nt-units shortly after NT as illustrated in Fig 1H. This
usually resulted from a failure of reprogramming of the somatic cell nucleus
because the majority of such units contained a single nucleus, suggesting that
the nucleus was not activated (Fig 1H). To examine whether the nt-units
contained human chromosomes, we performed karyotyping on nt-units at various
developmental stages. A total of 174 nt-units at 2-cell to blastocyst stages
were examined, and 9 metaphases with 46 chromosomes were captured. Gross
microscopic examination revealed no obvious abnormalities. Fig 3 displays a
metaphase spread showing apparent normal human chromosomes at the 300 band level
of resolution. These data demonstrate that nt-units are human in
origin.
Isolation and characterization of ntES cells
To isolate embryonic
stem cells, inner cell masses were dissected manually from blastocysts and
plated onto feeders of mouse fibroblasts in a culture medium described
previously[13]. We have tested three different types of media modified from
published work (refs.13-15, see also Materials and Methods), and all of them
were able to support the growth of ntES cells.
Several days
after plating of inner cell masses, colonies emerged with the ntES cell
morphology of flat colonies containing densely packed cells (Fig 4A-C). These
colonies were dissociated and passed on to new feeders. ntES cells expressed a
high level of alkaline phosphatase activity (Fig 4D). Marker expression was
examined with antibodies against SSEA-1, SSEA-3, SSEA-4, TRA-1-10, and
TRA-1-85[13]. ntES cells were positive for SSEA-3, SSEA-4, TRA-1-10, and
TRA-1-85 (Fig 4E-H) and negative for SSEA-1 just as conventional human ES cells
were in previous studies[13, 25]. Thus, with respect to marker expression, human
ntES cells showed no difference in comparison with conventional human ES
cells.
![]() |
¡¡ Fig 3. A G-banded karyotype from a 6-cell stage nt-unit The picture shows 22 pairs of autosomes and the two sex chromosomes. |
Over the past two years, we have
performed 289 NT experiments excluding the nt-units used for karyotyping. A
total of 2418 nt-units have been constructed by using rabbit oocytes fused to
human fibroblasts. 1086 (1086/2418, 44.9%) of these nt-units survived
electrofusion, and 158 blastocysts (158/1086, 14.5%) were obtained.
Approximately 2/3 of these were used to isolate ntES cells. Many continuously
renewing ntES cell populations have been isolated from blastocyst stage
nt-units. Among these populations, 14 were grown for more than 10 passages and 4
of them for more than 25 passages before cryopreservation (one at 28, one at 35
and two at 44 passages). In most culture conditions tested so far, these cells
grow as tightly packed colonies. Recently, some of the populations were adapted
to grow in monolayer on irradiated mouse feeders. Initial analysis of human and
rabbit mtDNAs show that both human and rabbit mtDNAs co-exist in ntES cells
(data not shown). In-depth analysis of dynamic changes of both mtDNA species in
undifferentiated and differentiated ntES cells is necessary. In addition, it is
also necessary to test culture conditions to facilitate expansion of ntES cells,
to characterize these cell populations regarding their doubling time, the
ability to form teratomas, and to search for conditions to grow ntES cells in
the absence of mouse feeder cells.
¡¡ Human ES cell lines express high levels of telomerase activity that seems to be correlated with immortality[13, 26]. Telomerase activity was quantified by use of a TRAP (Telomeric Repeat Amplification Protocol) assay (TeloTAGGG Telomerase PCR ELISA, Roche Diagnostics). Fibroblasts from individuals at three representative ages (5, 42, and 60 years) were telomerase negative, whereas the ntES cells derived from these fibroblasts by SCNT had high levels of telomerase activity. Thus, the human telomerase activity has been successfully reprogrammed (Fig 5).
![]() |
¡¡ Fig 6. Normal karyotype of ntES cells Metaphase preparation from ntES cells after 4 months of continuous culture. Karyotype: 46, XY, normal male. |
Somatic differentiation of ntES cells
Conditions that prompted differentiation
of conventional human ES or EG cells[13, 16] also induced differentiation of
ntES cells.
During passage in a medium containing leukemia
inhibitory factor, basic fibroblast growth factor, and forskolin, embryoid
bodies (EBs) formed above the plane of the monolayer and appeared under the
light microscope as ball-like structures with dark patches (Fig 10A). To induce
further differentiation, we transferred EBs to a medium composed of DMEM, 10%
FBS, antibiotics and 5 x10-7 M retinoic acid (Sigma). Within 1 to 2 days,
differentiated cells moved out from the EBs. After a 5-day retinoic acid
induction, the culture was transferred to a medium composed of DMEM, 10% FBS;
10% horse serum (Sigma), 1% chick embryo extract, and 50 units/ml
penicillin-streptomycin. Cells continued growth to a confluent cell sheet, with
the EB centrally located within the outgrowth (Fig 10B).Subpopulations of
differentiated cells were isolated and grown for limited passages. It was
confirmed that these differentiated cells contain primate nuclei that stain
positively with Alu probes (Fig 11).
In mouse, EB serves as a
unit for initial induction of ES cell differentiation, and a fully developed EB
often contains tissues expressing markers of the three germ layers[27, 28]. To
examine the inner structure of simple EBs formed by human ntES cells, we
prepared 5 ¦Ìm sections of frozen EBs and stained them with antibodies against
markers of the three germ layers. Inside the ball-like structure shown in Fig
10C-J, there were many undifferentiated cells that expressed few cell-type
specific markers. In the outer and bottom layers of EBs, we detected expression
of nestin (Fig 10C), neuron specific enolase (Fig 10D), [ectoderm]; myoglobin
(Fig 10E), ¦Á-smooth muscle actin (Fig 10F), VEGF receptor-2 (Fig 10G), Tie-2
(Fig 10H), [mesoderm]; ¦Á-fetoprotein (Fig 10I), and ¦Á-1-antitrypsin(Fig 10J),
endoderm].
Because outer layers of EBs were positive for a broad range of markers, we stained the outgrowth of EBs with a variety of dyes and antibodies to determine whether these cells were a homogeneous cell population or a mixture of heterogeneous cells. In the outgrowth of EBs, we detected cells with fat droplets that stained positive with the lipid dye Oil Red O (Fig 10K and Fig 10L). We also detected muscle cells with an elongated body and cytoplasm with myoglobin expression, a marker for muscle cells (Fig 10M and Fig 10N). Antibodies against ¦Á-fetoprotein and ¦Á-1-antitrypsin, markers of endoderm cell types, recognized groups of cells that grew into clusters with some localized patterns (Fig 10O and Fig 10P). In addition, small groups of cells in the outgrowth expressed markers of endothelial cells, such as VEGF receptor-2, Tie-2 and von Willebrand Factor (Fig 10Q-S). There were also sheets of flat cells that expressed markers associated with more than one cell type, for example, nestin (a marker for neuronal precursors, Fig 10T) and myoglobin (a marker for muscle cells, Fig 10U). The expression of MyoD1 was not detected in the outgrowth (Fig 10V). Based on these findings, it was obvious that the cells migrating immediately out of EBs were heterogeneous in marker expression. Expression of multiple cell type specific markers may be a property of certain types of stem cells[16]. The functional aspects of the heterogeneous cell types have not yet been analyzed.
Manipulation of the culture system altered the proportion of cell types in the population. For example, when cultures were switched, after retinoic acid induction, to a neuron-inducing medium com-posed of DMEM, 1% ITS (GIBCO), and 50 units/ml penicillin-streptomycin, the EBs gave rise to neurons (Fig 10W). Neuronal cells derived from ntES cells were positive for neurofilament-H (Fig 10X) and neuron-specific enolase (Fig 10Y). Nestin, strongly expressed in precursor cells, was weakly expressed in mature neurons (Fig 10Z).
DISCUSSION
In this study, we
demonstrate that human somatic cell nuclei can be reprogrammed to develop to the
balstocyst stage at least; reprogramming of human somatic nuclei can be achieved
through using non-human mammalian oocytes; ntES cells can be isolated from
nt-units at the blastocyst stage and they are capable of self-renewal and
differentiate into cells of all three germ layers.
ntES cells possess many properties of
human ES cells, including the origin from ICM, expression of surface markers,
special growth requirements, such as dependence in feeders
and independence
in leukemia inhibitory factors, capabilities of self-renewal, formation of
embryoid body and differentiation into cells of all three germ layers. Data
present in this paper therefore show that ntES cells meet majority, but not yet
all of the criteria set recently for human ES cells[29]. Further experiments are
necessary to prove that ntES cells have the same developmental potential as
conventional human ES cells.
The isolation of human embryonic stem cells, and the successful directed differentiation of these cells[13-15, 30] may result in an ability to correct various diseases through cellular transplantation. However, the use of human ES cell lines for transplantation will face immunological challenges as seen with the transplantation of organs. Here, we show that human embryonic stem cells, originating from a somatic cell nucleus, but without the use of a human egg, are capable of developing into cell types of all 3 germ layers. Therefore, nuclear transplantation appears to offer an opportunity to form stem cells in vitro from any given human patient. Although the fate of the mitochondria (rabbit/human) in these human ES cells remains unresolved, it is possible that these cells will be recognized as ¡®self¡¯ when transplanted back into the same patient.
Aside from its implication in medicine, reprogramming human somatic nuclei also provides a tool to study events occurring during the earliest stages of development. Molecular mechanisms governing fundamental biological phenomena, such as pluripotency, reprogramming, differentiation, and imprinting are currently unknown. Understanding those events may in turn bring new developments to improve human health.
ETHICAL REGULATIONS
All
experiments were performed in accordance with the guidelines on human stem cell
research (draft) issued by the Committee on Bioethics, Chinese National Human
Genome Center (Southern Headquarter), and endorsed by Shanghai Municipal
Government. The guidelines forbid human reproductive cloning, but allow research
on SCNT in humans for the purpose of deriving pluripotent stem cells from
somatic cells. The guidelines permit utilization of animal oocytes in human SCNT
for research purposes, but prohibit application of these cells for human use.
The guidelines prohibit combination of animal gametes with human gametes,
development of nt-units beyond a 14-day period, and the introduction of nt-units
into the uterus of any species. The guidelines also require that tissues used
for SCNT experiments must be obtained with informed consent from
donors.
ACKNOWLEDGEMENT
We are
grateful to Drs. M Brown, JL Goldstein, DL Garbers and R Hammer for critical
reading of the manuscript. We thank You Ming ZHU, Zheng Ya TANG, Wen Jun DING,
Chao PENG, Min Jie NI, and Yang WANG for their excellent technical support, and
Dr. Lan Dian HU for her assistance in DNA microsatellite analysis. Also, we
thank Dr. Li Jun ZHANG for karyotyping and Dr. Qiang Su GUO for assistance in
confocal microscopic analysis.
This work was supported by grants from the
Major State Basic Research Development Program of China (No. 001CB5099), the
National High Technology Research and Development Program of China (No.
2001AA216121), National Natural Science Foundation of China (No. 30040003),
Projects of Shanghai Science & Technology Development Foundation (No.
99DJ14002, 00DJ14033, 01DJ14003), the Chinese Academy of Sciences (No.
KSCX-2-3-08), Shanghai Municipal Education Commission and by Shanghai Second
Medical University.
REFERENCES
1 Solter D, J Gearhart. Putting stem cells to work. Science 1999;
283:1468-70.
2 Lanza RP, JB Cibelli, MD West. Human therapeutic cloning. Nature Med
1999;5:975-7.
3 Colman A, A Kind. Therapeutic cloning: concepts and practicalities.
Trends Biotechnol 2000; 18:192-6.
4 Cibelli JB, SL Stice, PJ Golueke, et al. Transgenic bovine chimeric
offspring produced from somatic cell-derived stem-like cells. Nature Biotechnol
¡¡ ¡¡1998; 16:642-6.
5 Munsie MJ, AE Michalska, CM O'Brien, AO Trounson, MF Pera, PS Mountford.
Isolation of pluripotent embryonic stem cells from reprogrammed adult ¡¡mouse somatic cell nuclei. Curr Biol 2000; 10:989-92.
6 Kawase E, Y Yamazaki, T Yagi, R Yanagimachi, RA Pedersen. Mouse embryonic
stem (ES) cell lines established from neuronal cell-derived cloned ¡¡blastocysts. Genesis 2000;¡¡28:156-63.
7 Wakayama T, V Tabar, I Rodriguez, AC Perry, L Studer, P Mombaerts.
Differentiation of embryonic stem cell lines generated from adult somatic cells
by ¡¡nuclear transfer. Science 2001; 292:740-3.
8 Simerly C, T Cominko, C Navara, et al. Molecular correlates of primate
nuclear transfer failures. Science 2003; 300:297.
9 Dominko T, M Mitalipova, B Haley, et al. Bovine oocyte cytoplasm supports
development of embryos produced by nuclear transfer of somatic cell nuclei ¡¡from various¡¡mammalian species. Biol Reprod 1999; 60:1496-1502.
10 Yang X, S Jiang, A Kov\'acs, RH Foote. Nuclear totipotency of cultured
rabbit morulae to support full-term development following nuclear transfer.
Biol ¡¡Reprod 1992;¡¡47:636-43.
11 Chesn¨¦ P, PG Adenot, C Viglietta, M Baratte, L Boulanger, JP Renard.
Cloned rabbits produced by nuclear transfer from adult somatic cells. Nature
¡¡Biotechnology 2002; 20:366-9.
12 Chen DY, QY Sun, JL Liu, et al. Dedifferentiation of giant panda (Ailuropoda
melanoleuca) somatic nuclei in rabbit ooplasm and early development of ¡¡the reconstructed egg. Science in China (Series C) 1999; 29:324-330.
13 Thomson JA, J Itskovitz-Eldor, SS Shapiro, et al. Embryonic stem cell
lines derived from human blastocysts. Science 1998; 282:1145-7.
14 Itskovitz-Eldor J, M Schuldiner, D Karsenti, et al. Differentiation
of human embryonic stem cells into embryoid bodies compromising the three ¡¡embryonic germ layers.Mol Med 2000; 6:88-95.
15 Reubinoff BE, MF Pera, CY Fong, A Trounson, A Bongso. Embryonic stem
cell lines from human blastocysts: somatic differentiation in vitro. Nature
¡¡Biotechnol 2000; 18:399-404.
16 Shamblott MJ, J Axelman, JW Littlefield, et al. Human embryonic germ
cell derivatives express a broad range of developmentally distinct markers and
¡¡proliferate extensively in vitro. Proc Natl Acad Sci USA 2001; 98:113-8.
17 Sambrook J, DW Russell. Molecular Cloning: a Laboratory Manual. (Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, New York). 2001.
18 Br¨²stle O, K Choudhary, K Karram, et al. Chimeric brains generated
by intraventricular transplantation of fetal human brain cells into embryonic
rats. ¡¡Nat Biotechnol 1998; 16:1040-4.
19 Rubin CM, CM Houck, PL Deininger, T Friedmann, CW Schmid. Partial
nucleotide sequence of the 300-nucleotide interspersed repeated human DNA ¡¡sequences. Nature 1980; 284:372-4.
20 Van de Corput MP, JM van den Ouweland, RW Dirks, LM Hart, GJ Bruining,
JA Maassen, AK Raap. Detection of mitochondrial DNA deletions in ¡¡human skin fibroblasts of patients with Pearson's syndrome by two-color
fluorescence in situ hybridization. J Histochem Cytochem 1997; 45:55-61.
21 Dunham I, C Lengauer, T Cremer, T Featherstone. Rapid generation of
chromosome-specific alphoid DNA probes using the polymerase chain reaction.
¡¡Hum Genet 1992; 88:457-62.
22 Wakayama T, R Yanagimachi. Mouse cloning with nucleus donor cells
of different age and type. Mol Reprod Dev 2001; 58:376-83.
23 Kubota C, H Yamakuchi, J Todoroki, et al. Six cloned calves produced
from adult fibroblast cells after long-term culture. Proc Natl Acad Sci USA
2000; ¡¡97:990-5.
24 Wang WH, L Meng, RJ Hackett, R Odenbourg, DL Keefe. The spindle observation
and its relationship with fertilization after intracytoplasmic sperm ¡¡injection in living human oocytes. Fertility and Sterility 2001; 75:348-53.
25 Pera MF, B Reubinoff, A Trounson. Human embryonic stem cells. J Cell
Sci 2000; 113:5-10.
26 Kim NW, MA Piatyszek, KR Prowse, et al. Specific association of human
telomerase activity with immortal cells and cancer. Science 1994; 266:2011-¡¡5.
27 Doetschman TC, H Eistetter, M Katz, W Schmidt, R Kemler. The in vitro
development of blastocyst-derived embryonic stem cell lines: formation of ¡¡visceral yolk sac, blood islands and myocardium. J Embryol Exp Morph 1985;
87:27-45.
28 Rathjen PD, J Lake, LM Whyatt, MD Bettess, J Rathjen. Properties and
uses of embryonic stem cells: prospects for application to human biology and
¡¡gene therapy. Reprod Fertil Dev 1998; 10:31-47.
29 Brivanlou AH, FH Gage, R Jaenisch, T Jessell, D Melton, J Rossant.
Setting standards for human embryonic stem cells. Science 2003; 300:913-6.
30 Odorico JS, DS Kaufman, JA Thomson. Multilineage differentiation from
human embryonic stem cell lines. Stem Cells 2001; 19:193-204.
Download the PDF
file of this paper
¡¡
Cell Research Online (CRO) published bimonthly
¡¡¡¡copyrighted©2003 journal of Cell Research
suggested resolution 1024*768